NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 1 filers reported holding NURIX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,155 | -21.3% | 27,119 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $270,919 | +12.5% | 27,119 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $240,817 | -19.1% | 27,119 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $297,767 | +84253.3% | 27,119 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $353 | -99.8% | 27,119 | +60.8% | 0.00% | 0.0% |
| Q2 2022 | $214,000 | -9.3% | 16,862 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $236,000 | -42.6% | 16,862 | +18.8% | 0.00% | 0.0% |
| Q4 2021 | $411,000 | -3.3% | 14,188 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $425,000 | – | 14,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |